14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $12.37 $16.85 Thursday, 25th Apr 2024 URGN stock ended at $13.82. This is 2.74% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 5.30% from a day low at $13.77 to a day high of $14.50.
90 days $12.37 $19.87
52 weeks $8.69 $24.13

Historical UroGen Pharma Ltd prices

Date Open High Low Close Volume
Oct 25, 2023 $11.50 $11.50 $11.17 $11.31 142 501
Oct 24, 2023 $11.25 $11.86 $11.25 $11.55 245 077
Oct 23, 2023 $11.80 $11.94 $11.20 $11.22 222 548
Oct 20, 2023 $11.47 $12.06 $11.40 $11.89 163 722
Oct 19, 2023 $11.71 $11.76 $11.23 $11.33 314 829
Oct 18, 2023 $11.90 $12.16 $11.52 $11.67 241 374
Oct 17, 2023 $13.12 $13.90 $11.84 $12.07 770 983
Oct 16, 2023 $13.01 $13.34 $12.98 $13.07 237 470
Oct 13, 2023 $13.02 $13.23 $12.82 $13.10 146 832
Oct 12, 2023 $13.29 $13.29 $12.74 $13.08 174 009
Oct 11, 2023 $13.73 $13.78 $13.22 $13.47 134 338
Oct 10, 2023 $13.25 $13.94 $13.23 $13.75 188 466
Oct 09, 2023 $13.64 $13.64 $12.93 $13.38 128 961
Oct 06, 2023 $13.55 $14.05 $13.50 $13.70 236 563
Oct 05, 2023 $13.29 $13.90 $13.29 $13.55 209 614
Oct 04, 2023 $14.20 $14.20 $13.29 $13.38 328 133
Oct 03, 2023 $13.94 $14.52 $13.59 $13.87 294 896
Oct 02, 2023 $14.00 $14.25 $13.65 $13.69 265 270
Sep 29, 2023 $14.30 $14.73 $13.94 $14.01 196 923
Sep 28, 2023 $15.04 $15.08 $14.01 $14.29 445 012
Sep 27, 2023 $15.46 $15.56 $14.59 $15.09 186 444
Sep 26, 2023 $15.80 $16.53 $15.31 $15.44 271 093
Sep 25, 2023 $15.66 $15.88 $15.22 $15.81 95 843
Sep 22, 2023 $15.81 $16.05 $15.44 $15.69 108 440
Sep 21, 2023 $15.67 $16.16 $15.45 $15.80 118 877
Click to get the best stock tips daily for free!

About UroGen Pharma Ltd

UroGen Pharma Ltd UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms... URGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT